Sep 17, 2018 - A new migraine drug is a big win amid the turnaround of generics business.
Sep 16, 2015 - GW Pharmaceuticals plc (GWPH) announced encouraging top-line data from an exploratory phase IIa study on cannabidiol in patients suffering from schizophrenia who had previously failed to respond adequately to first-line anti-psychotic medications.
Apr 21, 2017 - Earnings Growth Accelerates in Q1
Jul 24, 2018 - Names on the move ahead of the open.
Jan 27, 2017 - Earnings Growth Returns, Will it Continue?
Jun 27, 2017 - Disappointing phase 3 trial results are increasing concerns that its migraine drug might not be a commercial success.
Apr 17, 2017 - Despite a climbing market, these stocks fell. Find out why.
Apr 18, 2017 - Drugmakers get denied, Chipotle continues gains, and earnings season gets under way. Investors have remained optimistic ahead of what could be a tumultuous week.
May 31, 2017 - Aales of diabetes drugs from most large pharma companies slipped in the first quarter.
Sep 05, 2017 - An update on bariticinib's review timeline has Wall Street rightly excited.